Revolution Medicines Inc [RVMD] stock prices are up 2.05% to $38.04 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The RVMD shares have gain 5.20% over the last week, with a monthly amount glided 2.78%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Revolution Medicines Inc [NASDAQ: RVMD] stock has seen the most recent analyst activity on August 19, 2025, when Piper Sandler initiated its Overweight rating and assigned the stock a price target of $75. Previously, Wells Fargo started tracking the stock with Overweight rating on August 15, 2025, and set its price target to $67. On July 15, 2025, Goldman initiated with a Buy rating and assigned a price target of $65 on the stock. Needham reiterated its Buy rating and increased its price target to $62 on July 16, 2024. Barclays initiated its recommendation with a Overweight and recommended $52 as its price target on July 12, 2024. Jefferies started tracking with a Buy rating for this stock on July 08, 2024, and assigned it a price target of $63. In a note dated April 12, 2024, Needham reiterated an Buy rating on this stock and boosted its target price from $36 to $46.
The stock price of Revolution Medicines Inc [RVMD] has been fluctuating between $29.17 and $62.40 over the past year. Currently, Wall Street analysts expect the stock to reach $70.33 within the next 12 months. Revolution Medicines Inc [NASDAQ: RVMD] shares were valued at $38.04 at the most recent close of the market. An investor can expect a potential return of 84.88% based on the average RVMD price forecast.
Analyzing the RVMD fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.33, Equity is -0.42 and Total Capital is -0.4. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.07.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 36.37 points at the first support level, and at 34.70 for the second support level. However, for the 1st resistance point, the stock is sitting at 38.98, and for the 2nd resistance point, it is at 39.92.
Ratios To Look Out For
It’s worth pointing out that Revolution Medicines Inc [NASDAQ:RVMD]’s Current Ratio is 11.79. In addition, the Quick Ratio stands at 11.79 and the Cash Ratio stands at 2.18.
Transactions by insiders
Recent insider trading involved Cislini Jeff, General Counsel, that happened on Jun 20 ’25 when 1912.0 shares were sold. Officer, JEFFREY TODD CISLINI completed a deal on Jun 20 ’25 to buy 1912.0 shares. Meanwhile, Chief Operating Officer Horn Margaret A sold 3510.0 shares on Jun 16 ’25.
